药剂师主导的干预方案在选择性心血管手术后预防术后狂妄症的影响
Yuki Asai1, Tatsuki Yanagawa1, Masaaki Takahashi1
1Pharmacy, National Hospital Organization Mie Chuo Medical Center, Hisaimyojin, Tsu, Mie, Japan.
PloS one
|October 12, 2023
概括
使用基于协议的药物管理 (PBPM) 的药剂师主导的干预措施显著降低了心血管手术患者的术后狂妄症 (PD) 率. 这种方法确定了多药作为一个关键的风险因素,导致减少了二二的使用和改善了患者的治疗结果.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 心血管外科心血管外科
- 神经科学和神经病学 神经科学和神经病学
背景情况:
- 手术后妄 (PD) 是心血管手术后的常见并发症,目前药剂师干预的成功程度有限.
- 识别与药物治疗相关的风险因素对于制定有效的预防PD策略至关重要.
研究的目的:
- 在接受选择性心血管手术的患者中识别PD的药物治疗风险因素.
- 评估使用基于协议的药物管理 (PBPM) 的药剂师主导干预措施在降低PD率方面的有效性.
主要方法:
- 对142名接受选择性门置换或膜整形手术的成年患者进行了回顾性队列研究.
- 多变量逻辑回归分析以确定PD风险因素,重点是药物治疗.
- 实施PBPM协议,在高风险患者中停止使用二类药物,并用ramelteon/suvorexant替代 (多药,频繁剂量,二类药物使用/失眠).
主要成果:
- 总体的PD率为25%. 多药性是一个显著的风险因素 (调整后OR为3.3,p=0.016).
- 患病率显著下降,从PBPM前组的33%降至PBPM后组的13% (p=0.014).
- PBPM导致二二胺使用量减少 (p=0.026) 和使用拉梅尔和素受体对抗剂增加 (p<0.001).
结论:
- 基于协议的药物管理,针对二二胺的减少和替代性催眠使用,有效地降低了心血管手术患者的PD率.
- 对多种药物的术前评估对于识别患有PD高风险的患者至关重要.
- 这种由药剂师主导的干预是心血管外科手术中PD风险评估和管理的简单且潜在有用的策略.
相关概念视频
Cardiomyopathy VII: Pre and Post Operative Nursing Management
15
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
97
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
97
Cardiac Catheterization IV: Nursing Management
31
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
31
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9


